Clinical Trials · NCT07171723
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
- Phase
- EARLY_Phase 1
- Recruitment status
- Completed
- Sponsor
- University Hospital, Gentofte, Copenhagen
- Enrollment
- 24
- Start date
- Sep 2025
- Locations
- 1 site, Denmark
- Primary endpoint
- Food intake